Cargando…
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel
BACKGROUND: ARHI is a Ras-related imprinted gene that inhibits cancer cell growth and motility. ARHI is downregulated in the majority of breast cancers, and loss of its expression is associated with its progression from ductal carcinoma in situ (DCIS) to invasive disease. In ovarian cancer, re-expre...
Autores principales: | Zou, Chun-Fang, Jia, Luoqi, Jin, Hongyan, Yao, Ming, Zhao, Naiqing, Huan, Jin, Lu, Zhen, Bast, Robert C, Feng, Youji, Yu, Yinhua |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032751/ https://www.ncbi.nlm.nih.gov/pubmed/21244707 http://dx.doi.org/10.1186/1471-2407-11-22 |
Ejemplares similares
-
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models
por: Ornelas, Argentina, et al.
Publicado: (2016) -
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
por: Washington, M N, et al.
Publicado: (2015) -
Tú dirás!
por: Gutiérrez, Jhon R.
Publicado: (1999) -
DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1
por: Sutton, Margie N., et al.
Publicado: (2019) -
Re-expression of DIRAS3 and p53 induces apoptosis and impaired autophagy in head and neck squamous cell carcinoma
por: Liu, Zhe, et al.
Publicado: (2020)